Verition Fund Management
RGNX icon

Verition Fund Management’s Regenxbio RGNX Stock Holding History

Verition Fund Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,579
Closed -$111K – 3824
2025
Q1 		$111K Sell
15,579
-10,290
-40% -$76.5K ﹤0.01% 3144
2024
Q4 		$200K Sell
25,869
-15,277
-37% -$143K ﹤0.01% 2977
2024
Q3 		$432K Buy
+41,146
New +$502K ﹤0.01% 2409
2023
Q3 		– Sell
-20,158
Closed -$403K – 2629
2023
Q2 		$403K Buy
+20,158
New +$388K 0.01% 1353
2021
Q2 		– Sell
-6,269
Closed -$214K – 2096
2021
Q1 		$214K Buy
+6,269
New +$267K ﹤0.01% 1301
2020
Q1 		– Sell
-5,561
Closed -$228K – 984
2019
Q4 		$228K Buy
+5,561
New +$220K ﹤0.01% 920

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Verition Fund Management's RGNX Position: Q2 2025 in Review

Verition Fund Management sold out of Regenxbio (RGNX) in Q2 2025, closing a stake of 15,579 shares — an estimated $111K sold.

Verition Fund Management first reported a position in RGNX in Q4 2019 and held it in 6 quarters. The position peaked at $432K in Q3 2024. 159 funds tracked by Wall St. Rank hold RGNX as of Q2 2025.

  • Verition Fund Management reported no remaining Regenxbio position as of Q2 2025 after selling out during the quarter.
  • Verition Fund Management sold 15,579 Regenxbio shares in Q2 2025, an estimated $111K.
  • Verition Fund Management first reported a position in Regenxbio in Q4 2019 and held it in 6 quarters.
  • Verition Fund Management's Regenxbio position peaked at $432K in Q3 2024.
  • 159 funds tracked by Wall St. Rank held Regenxbio as of Q2 2025.

Based on Verition Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.